Rastreamento de câncer cervical

Última revisión: 20 Aug 2025
Última actualización: 19 Mar 2025

Resumen

Datos

  • Técnicas de amostragem cervical
  • Citologia cervical
  • teste de vírus do papiloma humano (HPV)
  • Vacinação contra o papilomavírus humano (HPV)
  • Colposcopia
Todos los datos

Colaboradores

Autores

Richard T. Penson, MD, MRCP
Richard T. Penson

Medical Gynecologic Oncology

Division of Hematology Oncology

Massachusetts General Hospital

Boston

MA

Divulgaciones

RTP reports personal fees for advisory boards from Aadi Bioscience, AstraZeneca, GSK Inc., ImmunoGen Inc., Merck & Co., Mersana, Novacure, Roche Pharma, Sutro Biopharma, and Vascular Biogenics Ltd; serves on Drug Safety and Monitoring Boards for AstraZeneca, EQRx, and Roche Pharma; Institutional research funding (as Principal Investigator) for Array BioPharma Inc., AstraZeneca., Eisai Inc., Genentech, Inc., Vascular Biogenics Ltd; and royalties from BMJ Publishing, UptoDate, Elsevier Ltd., Wolters Kluwer Health, and Wiley Blackwell. Payment for educational events: Research to Practice, ExpertConnect, ReachMD, CMEO Outfitters.

Marcela G. del Carmen, MD, MPH
Marcela G. del Carmen

President

Massachusetts General Physicians Organization

Division of Gynecologic-Oncology

Massachusetts General Hospital

Professor

Department of Obstetrics, Gynecology and Reproductive Biology

Harvard Medical School

Boston

MA

Divulgaciones

MDC declares that she has no competing interests.

Revisores por pares

Diane M. Harper, MD, MPH, MS

Professor

Departments of Family Medicine and Obstetrics and Gynecology

University of Michigan

Ann Arbor

MI

Divulgaciones

DMH has been paid through a grant from Roche to the University of Michigan.

Deirdre Lyons, MB, BCh, BAO, MRCOG

Consultant in Obstetrics & Gynaecology

Lead Clinician in Colposcopy

Imperial College Healthcare NHS Trust

London

UK

Divulgaciones

DL declares that she has no competing interests.

Matejka Rebolj, PhD

Scientific Researcher

Centre for Epidemiology and Screening

Institute of Public Health

University of Copenhagen

Copenhagen

Denmark

Divulgaciones

MR declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Fontham ETH, Wolf AMD, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020 Sep;70(5):321-46.Texto completo  Resumen

Sawaya GF, Kulasingam S, Denberg TD, et al. Cervical cancer screening in average-risk women: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med. 2015;162:851-9.Texto completo  Resumen

US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018 Aug 21;320(7):674-86.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad